Cellularis Biomodels is a deep-tech company that provides state-of-the-art 3D of human disease for screening candidate therapies in the preclinical phase. Cellularis' leverages on deep expertise in bioengineering, cell-technologies, 3D biofabrication, and biochemistry, providing living screening platforms and expert advice for preclinical drug discovery and development pipelines. Our proprietary bioengineering technologies enable the production of physiomimetic 3D disease models that recapitulate key tumor-stroma hallmarks, bioarchitecture and anatomic scale in an in vitro setting. The company development pipeline includes 3D in vitro tumor-stroma models of Pancreatic, Breast, Prostate and Lung cancer combining cells and extracellular matrix biomaterials to mimic the tumor microenvironment. Cellularis Biomodels aims to advance the preclinical screening toolbox while contributing to reducing animal experimentation for therapeutics validation.